2021/04/14 18:07 Surfers riding wave in Waikiki. (Hawaii Tourism Authority photo) Surfers riding wave in Waikiki. (Hawaii Tourism Authority photo) TAIPEI (Taiwan News) Travelers from Taiwan who present proof of negative coronavirus tests from select hospitals will be exempt from Hawaii s mandatory 10-day quarantine starting on Saturday (April 17). In order to keep Hawaii s number of coronavirus cases down to the relatively low number of 31,000, the state requires all visitors, whether domestic or foreign, to undergo a 10-day self-quarantine upon arrival. However, Mackay Memorial Hospital on Wednesday (April 14) announced that the Hawaii Department of Health (DOH) has given the green light to an exemption for travelers from Taiwan who can present negative results of a nucleic acid amplification test (NAAT) for COVID-19 from a hospital approved by Taiwan s Ministry of Health and Welfare.
Hawaii s pre-travel testing program expanded to Taiwan kitv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kitv.com Daily Mail and Mail on Sunday newspapers.
Taiwan to offer genetic testing for treatment of 6 cancers | Taiwan News taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.
Taiwan to offer genetic testing for treatment of 6 cancers
03/05/2021 09:58 PM
Pixabay image for illustrative purposes only
Taipei, March 5 (CNA) Taiwan s Ministry of Health and Welfare (MOHW) has announced that it plans to launch a pilot program to offer genetic tests for the targeted treatment of six types of cancer, with the aim of helping the pharmaceutical industry develop medicine catered to individuals genes and lifestyle, and boosting patients chances of survival.
More than 1,000 patients will be enrolled in the program by the second half of this year, according to the MOHW.
The program, jointly developed by the MOHW, the National Health Research Institutes (NHRI) and Roche Diagnostics Taiwan, will allow patients at a network of designated hospitals to have samples of their cancer analyzed for a range of possible mutations.